Clinical Trial Update: The INDORSE Study: Inhibition of Dipeptidyl Peptidase IV: Outcomes on Renal Sodium Excretion [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of dipeptidyl peptidase-4 inhibition on renal sodium excretion in adults with Type 2 diabetes; results completed an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: University Health Network, Toronto | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2018-04-05